Condition: Chondral Defect · Osteochondritis Dissecans (OCD) · Articular Cartilage Defect · Sponsor: Vericel Corporation
The objective of this study is to compare the efficacy and safety of MACI® vs arthroscopic microfracture in the treatment of participants aged 10 to 17 years with symptomatic articular chondral or osteochondral defects of the knee.
This description comes directly from the study's public registry record.
Vericel Clinical Affairs · 978-347-2876 · clinicalhotline@vcel.com
Always discuss trial participation with your own doctor first.
| Stanford University | Palo Alto, California, United States | Recruiting |
| Shriner's Hospital for Children Northern California | Sacramento, California, United States | Recruiting |
| University of California Davis Health | Sacramento, California, United States | Recruiting |
| Ochsner Sports Medicine Institute | New Orleans, Louisiana, United States | Recruiting |
| Johns Hopkins Outpatient Center | Baltimore, Maryland, United States | Recruiting |
| University of Michigan | Ann Arbor, Michigan, United States | Recruiting |
| Akron Children's Hospital | Akron, Ohio, United States | Recruiting |
| The Ohio State University Jameson Crane Sports Medicine Institute | Columbus, Ohio, United States | Recruiting |
| Children's Hospital of Philadelphia | Philadelphia, Pennsylvania, United States | Recruiting |
| Penn Sports Medicine Center | Philadelphia, Pennsylvania, United States | Recruiting |
| Texas Children's Hospital | Houston, Texas, United States | Withdrawn |
| Medical College of Wisconsin | Milwaukee, Wisconsin, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03588975